An analog medical thermometer showing a temperature of 38.8 °C or 101.8 °F
Fever (also known as pyrexia or febrile response) is one of the most common medical signs and is characterized by an elevation of body temperature above the normal range of 36.5–37.5 °C (97.7–99.5 °F) due to an increase in the temperature regulatory set-point. This increase in set-point triggers increased muscle tone and chills.
As a person's temperature increases, there is, in general, a feeling of cold despite an increase in body temperature. Once body temperature has increased to the new set-point temperature, there is a feeling of warmth. A rapid decrease in temperature may be accompanied by sweating and feeling hot.
A fever can be caused by many medical conditions which range from benign to potentially serious. Some studies suggest that fever is useful as a defense mechanism as the body's immune response can be strengthened at higher temperatures; however, there are arguments for and against the usefulness of fever, and the issue is controversial. With the exception of very high temperatures, treatment to reduce fever is often not necessary; however, antipyretic medications can be effective at lowering the temperature, which may improve the affected person's comfort.
Fever differs from uncontrolled hyperthermia, in that hyperthermia is an increase in body temperature over the body's thermoregulatory set-point, due to excessive heat production or insufficient thermoregulation.
- 1 Definition
- 2 Signs and symptoms
- 3 Differential diagnosis
- 4 Pathophysiology
- 5 Management
- 6 Epidemiology
- 7 History
- 8 Society and culture
- 9 Other animals
- 10 References
- 11 Further reading
- 12 External links
|Hypothermia||<35.0 °C (95.0 °F)|
|Normal||36.5–37.5 °C (97.7–99.5 °F)|
|Fever||>37.5 or 38.3 °C (99.5 or 100.9 °F)|
|Hyperthermia||>37.5 or 38.3 °C (99.5 or 100.9 °F)|
|Hyperpyrexia||>40.0 or 41.5 °C (104.0 or 106.7 °F)|
Note: The difference between fever and hyperthermia is the underlying mechanism.
Different sources have different cuts offs for fever, hyperthermia and hyperpyrexia.
- Temperature in the anus (rectum/rectal) is at or over 37.5–38.3 °C (99.5–100.9 °F)
- Temperature in the mouth (oral) is at or over 37.7 °C (99.9 °F)
- Temperature under the arm (axillary) or in the ear (otic) is at or over 37.2 °C (99.0 °F)
In healthy adult men and women, the range of normal, healthy temperatures for oral temperature is 33.2–38.2 °C (91.8–100.8 °F), for rectal it is 34.4–37.8 °C (93.9–100.0 °F), for tympanic membrane (the ear drum) it is 35.4–37.8 °C (95.7–100.0 °F), and for axillary (the armpit) it is 35.5–37.0 °C (95.9–98.6 °F). Harrison's textbook of internal medicine defines a fever as a morning oral temperature of >37.2 °C (>98.9 °F) or an afternoon oral temperature of >37.7 °C (>99.9 °F) while the normal daily temperature variation is typically 0.5 °C (0.9 °F).
Normal body temperatures vary depending on many factors, including age, sex, time of day, ambient temperature, activity level, and more. A raised temperature is not always a fever. For example, the temperature of a healthy person rises when he or she exercises, but this is not considered a fever, as the set-point is normal. On the other hand, a "normal" temperature may be a fever, if it is unusually high for that person. For example, medically frail elderly people have a decreased ability to generate body heat, so a "normal" temperature of 37.3 °C (99.1 °F) may represent a clinically significant fever.
The pattern of temperature changes may occasionally hint at the diagnosis:
- Continuous fever: Temperature remains above normal throughout the day and does not fluctuate more than 1 °C in 24 hours, e.g. lobar pneumonia, typhoid, urinary tract infection, brucellosis, or typhus. Typhoid fever may show a specific fever pattern (Wunderlich curve of typhoid fever), with a slow stepwise increase and a high plateau. (Drops due to fever-reducing drugs are excluded.)
- Intermittent fever: The temperature elevation is present only for a certain period, later cycling back to normal, e.g. malaria, kala-azar, pyaemia, or septicemia. Following are its types 
- Remittent fever: Temperature remains above normal throughout the day and fluctuates more than 1 °C in 24 hours, e.g., infective endocarditis.
- Pel-Ebstein fever: A specific kind of fever associated with Hodgkin's lymphoma, being high for one week and low for the next week and so on. However, there is some debate as to whether this pattern truly exists.
A neutropenic fever, also called febrile neutropenia, is a fever in the absence of normal immune system function. Because of the lack of infection-fighting neutrophils, a bacterial infection can spread rapidly; this fever is, therefore, usually considered to require urgent medical attention. This kind of fever is more commonly seen in people receiving immune-suppressing chemotherapy than in apparently healthy people.
Febricula is an old term for a low-grade fever, especially if the cause is unknown, no other symptoms are present, and the patient recovers fully in less than a week.
Hyperpyrexia is a fever with an extreme elevation of body temperature greater than or equal to 41.5 °C (106.7 °F). Such a high temperature is considered a medical emergency as it may indicate a serious underlying condition or lead to significant side effects. The most common cause is an intracranial hemorrhage. Other possible causes include sepsis, Kawasaki syndrome, neuroleptic malignant syndrome, drug effects, serotonin syndrome, and thyroid storm. Infections are the most common cause of fevers, however as the temperature rises other causes become more common. Infections commonly associated with hyperpyrexia include roseola, rubeola and enteroviral infections. Immediate aggressive cooling to less than 38.9 °C (102.0 °F) has been found to improve survival. Hyperpyrexia differs from hyperthermia in that in hyperpyrexia the body's temperature regulation mechanism sets the body temperature above the normal temperature, then generates heat to achieve this temperature, while in hyperthermia the body temperature rises above its set point due to an outside source.
Hyperthermia is an example of a high temperature that is not a fever. It occurs from a number of causes including heatstroke, neuroleptic malignant syndrome, malignant hyperthermia, stimulants such as amphetamines and cocaine, idiosyncratic drug reactions, and serotonin syndrome.
Signs and symptoms
Fever is a common symptom of many medical conditions:
- Infectious disease, e.g., influenza, HIV, malaria, Ebola, infectious mononucleosis, or gastroenteritis, Lyme disease
- Various skin inflammations, e.g., boils, or abscess
- Immunological diseases, e.g., lupus erythematosus, sarcoidosis, inflammatory bowel diseases, Kawasaki disease, Still disease, Horton disease, Wegener disease, Hepatitis autoimmune
- Tissue destruction, which can occur in hemolysis, surgery, infarction, crush syndrome, rhabdomyolysis, cerebral hemorrhage, etc.
- Reaction to incompatible blood products
- Cancers, most commonly kidney cancer and leukemia and lymphomas
- Metabolic disorders, e.g., gout or porphyria
- Thrombo-embolic processes, e.g., pulmonary embolism or deep venous thrombosis
Persistent fever that cannot be explained after repeated routine clinical inquiries is called fever of unknown origin.
Temperature is ultimately regulated in the hypothalamus. A trigger of the fever, called a pyrogen, causes a release of prostaglandin E2 (PGE2). PGE2 then in turn acts on the hypothalamus, which generates a systemic response back to the rest of the body, causing heat-creating effects to match a new temperature level.
In many respects, the hypothalamus works like a thermostat. When the set point is raised, the body increases its temperature through both active generation of heat and retaining heat. Vasoconstriction both reduces heat loss through the skin and causes the person to feel cold. If these measures are insufficient to make the blood temperature in the brain match the new setting in the hypothalamus, then shivering begins in order to use muscle movements to produce more heat. When the fever stops, and the hypothalamic setting is set lower; the reverse of these processes (vasodilation, end of shivering and nonshivering heat production) and sweating are used to cool the body to the new, lower setting.
This contrasts with hyperthermia, in which the normal setting remains, and the body overheats through undesirable retention of excess heat or over-production of heat. Hyperthermia is usually the result of an excessively hot environment (heat stroke) or an adverse reaction to drugs. Fever can be differentiated from hyperthermia by the circumstances surrounding it and its response to anti-pyretic medications.
A pyrogen is a substance that induces fever. These can be either internal (endogenous) or external (exogenous) to the body. The bacterial substance lipopolysaccharide (LPS), present in the cell wall of some bacteria, is an example of an exogenous pyrogen. Pyrogenicity can vary: In extreme examples, some bacterial pyrogens known as superantigens can cause rapid and dangerous fevers. Depyrogenation may be achieved through filtration, distillation, chromatography, or inactivation.
In essence, all endogenous pyrogens are cytokines, molecules that are a part of the immune system. They are produced by activated immune cells and cause the increase in the thermoregulatory set point in the hypothalamus. Major endogenous pyrogens are interleukin 1 (α and β) and interleukin 6 (IL-6). Minor endogenous pyrogens include interleukin-8, tumor necrosis factor-β, macrophage inflammatory protein-α and macrophage inflammatory protein-β as well as interferon-α, interferon-β, and interferon-γ. Tumor necrosis factor-α also acts as a pyrogen. It is mediated by interleukin 1 (IL-1) release.
These cytokine factors are released into general circulation, where they migrate to the brain due to easier absorption caused by the blood–brain barrier's reduced filtration action there. The cytokine factors then bind with endothelial receptors on vessel walls, or interact with local microglial cells. When these cytokine factors bind, the arachidonic acid pathway is then activated.
One model for the mechanism of fever caused by exogenous pyrogens includes LPS, which is a cell wall component of gram-negative bacteria. An immunological protein called lipopolysaccharide-binding protein (LBP) binds to LPS. The LBP–LPS complex then binds to the CD14 receptor of a nearby macrophage. This binding results in the synthesis and release of various endogenous cytokine factors, such as interleukin 1 (IL-1), interleukin 6 (IL-6), and the tumor necrosis factor-alpha. In other words, exogenous factors cause release of endogenous factors, which, in turn, activate the arachidonic acid pathway.
PGE2 release comes from the arachidonic acid pathway. This pathway (as it relates to fever), is mediated by the enzymes phospholipase A2 (PLA2), cyclooxygenase-2 (COX-2), and prostaglandin E2 synthase. These enzymes ultimately mediate the synthesis and release of PGE2.
PGE2 is the ultimate mediator of the febrile response. The set point temperature of the body will remain elevated until PGE2 is no longer present. PGE2 acts on neurons in the endocrine organs.
The brain ultimately orchestrates heat effector mechanisms via the autonomic nervous system. These may be:
- Increased heat production by increased muscle tone, shivering and hormones like epinephrine (adrenaline)
- Prevention of heat loss, such as vasoconstriction.
In infants, the autonomic nervous system may also activate brown adipose tissue to produce heat (non-exercise-associated thermogenesis, also known as non-shivering thermogenesis). Increased heart rate and vasoconstriction contribute to increased blood pressure in fever.
There are arguments for and against the usefulness of fever, and the issue is controversial. There are studies using warm-blooded vertebrates and humans in vivo, with some suggesting that they recover more rapidly from infections or critical illness due to fever. A Finnish study suggested reduced mortality in bacterial infections when fever was present.
In theory, fever can aid in host defense. There are certainly some important immunological reactions that are sped up by temperature, and some pathogens with strict temperature preferences could be hindered.
Research has demonstrated that fever assists the healing process in several important ways:
- Increased mobility of leukocytes
- Enhanced leukocyte phagocytosis
- Endotoxin effects decreased
- Increased proliferation of T cells
Fever should not necessarily be treated. Most people recover without specific medical attention. Although it is unpleasant, fever rarely rises to a dangerous level even if untreated. Damage to the brain generally does not occur until temperatures reach 42 °C (107.6 °F), and it is rare for an untreated fever to exceed 40.6 °C (105 °F).
Some limited evidence supports sponging or bathing feverish children with tepid water. The use of a fan or air conditioning may somewhat reduce the temperature and increase comfort. If the temperature reaches the extremely high level of hyperpyrexia, aggressive cooling is required. In general, people are advised to keep adequately hydrated. Whether increased fluid intake improves symptoms or shortens respiratory illnesses such as the common cold is not known.
Medications that lower fevers are called antipyretics. The antipyretic ibuprofen is effective in reducing fevers in children. It is more effective than acetaminophen (paracetamol) in children. Ibuprofen and acetaminophen may be safely used together in children with fevers. The efficacy of acetaminophen by itself in children with fevers has been questioned. Ibuprofen is also superior to aspirin in children with fevers. Additionally, aspirin is not recommended in children and young adults (those under the age of 16 or 19 depending on the country) due to the risk of Reye's syndrome.
Using both paracetamol and ibuprofen at the same time or alternating between the two is more effective at decreasing fever than using only paracetamol or ibuprofen. It is not clear if it increases child comfort.
About 5% of people who go to an emergency room have a fever.
A number of types of fever were known as early as 460 BC to 370 BC when Hippocrates was practicing medicine including that due to malaria (tertian or every 2 days and quartan or every 3 days). It also became clear around this time that fevers were a symptom of a disease rather than a disease in and of itself.
Society and culture
Fever phobia is the name given by medical experts to parents' misconceptions about fever in their children. Among them, many parents incorrectly believe that fever is a disease rather than a medical sign, that even low fevers are harmful, and that any temperature even briefly or slightly above the oversimplified "normal" number marked on a thermometer is a clinically significant fever. They are also afraid of harmless side effects like febrile seizures and dramatically overestimate the likelihood of permanent damage from typical fevers. The underlying problem, according to professor of pediatrics Barton D. Schmitt, is "as parents we tend to suspect that our children’s brains may melt."
As a result of these misconceptions parents are anxious, give the child fever-reducing medicine when the temperature is technically normal or only slightly elevated, and interfere with the child's sleep to give the child more medicine.
Fever is an important feature for the diagnosis of disease in domestic animals. The body temperature of animals, which is taken rectally, is different from one species to another. For example, a horse is said to have a fever above 101 °F (38.3 °C). In species that allow the body to have a wide range of "normal" temperatures, such as camels, it is sometimes difficult to determine a febrile stage.
Fever can also be behaviorally induced by invertebrates that do not have immune-system based fever. For instance, some species of grasshopper will thermoregulate to achieve body temperatures that are 2 - 5 °C higher than normal in order to inhibit the growth of fungal pathogens such as Beauveria bassiana and Metarhizium acridum. Honeybee colonies are also able to induce a fever in response to a fungal parasite Ascosphaera apis. 
- Axelrod YK, Diringer MN; Diringer (May 2008). "Temperature management in acute neurologic disorders". Neurol Clin 26 (2): 585–603, xi.
- Karakitsos D, Karabinis A; Karabinis (September 2008). "Hypothermia therapy after traumatic brain injury in children". N. Engl. J. Med. 359 (11): 1179–80.
- Marx, John (2006). Rosen's emergency medicine: concepts and clinical practice. Mosby/Elsevier. p. 2239.
- Laupland KB (July 2009). "Fever in the critically ill medical patient". Crit. Care Med. 37 (7 Suppl): S273–8.
- Manson's Tropical Diseases: Expert Consult. Saunders. 2008. p. 1229.
- Trautner BW, Caviness AC, Gerlacher GR, Demmler G, Macias CG (July 2006). "Prospective evaluation of the risk of serious bacterial infection in children who present to the emergency department with hyperpyrexia (temperature of 106 degrees F or higher)". Pediatrics 118 (1): 34–40.
- Barone JE (August 2009). "Fever: Fact and fiction". J Trauma 67 (2): 406–9.
- Sund-Levander M, Forsberg C, Wahren LK; Forsberg; Wahren (June 2002). "Normal oral, rectal, tympanic and axillary body temperature in adult men and women: a systematic literature review". Scand J Caring Sci 16 (2): 122–8.
- Harrison's principles of internal medicine. (18th ed.). New York: McGraw-Hill. 2011. p. 4012.
- Muhammad, Inayatullah; Shabbir Ahmad Nasir (May 2009). Bedside Techniques: Methods of clinical examination. Saira Publishers and Salamat Iqbal Press,
- Hilson AJ (July 1995). "Pel-Ebstein fever". N. Engl. J. Med. 333 (1): 66–7. . They cite Richard Asher's lecture Making Sense (Lancet, 1959, 2, 359)
- Rolla L. Thomas (1906) . The eclectic practice of medicine. The Scudder Brothers Company. p. 261.
- Loscalzo, Joseph; Fauci, Anthony S.; Braunwald, Eugene; Dennis L. Kasper; Hauser, Stephen L; Longo, Dan L. (2008). "Chapter 17, Fever versus hyperthermia". Harrison's principles of internal medicine. McGraw-Hill Medical.
- McGugan EA (March 2001). "Hyperpyrexia in the emergency department". Emerg. Med. (Fremantle) 13 (1): 116–20.
- Marx 2006, p. 2506
- Hart, BL (1988). "Biological basis of the behavior of sick animals". Neuroscience and biobehavioral reviews 12 (2): 123–37.
- Johnson, RW (2002). "The concept of sickness behavior: a brief chronological account of four key discoveries". Veterinary immunology and immunopathology 87 (3–4): 443–50.
- Kelley, KW, Bluthé, RM, Dantzer, R, Zhou, JH, Shen, WH, Johnson, RW, Broussard, SR (2003). "Cytokine-induced sickness behavior". Brain, behavior, and immunity. 17 Suppl 1: S112–8.
- Chapter 58 in: Walter F., PhD. Boron (2003). Medical Physiology: A Cellular And Molecular Approaoch. Elsevier/Saunders. p. 1300.
- Stefferl, Andreas; Stephen J. Hopkins, Nancy J. Rothwell & Giamal N. Luheshi (April 25, 1996). "The role of TNF-a in fever: opposing actions of human and murine TNF-oa and interactions with IL-fl in the rat". Brftish Journal of Pharmacology 118 (8): 1919–1924.
- Schaffner, A (2006). "Fever--useful or noxious symptom that should be treated?". Therapeutische Umschau. Revue therapeutique 63 (3): 185–8.
- Soszyński, D (2003). "The pathogenesis and the adaptive value of fever". Postepy higieny i medycyny doswiadczalnej 57 (5): 531–54.
- Su, F, Nguyen, ND, Wang, Z, Cai, Y, Rogiers, P, Vincent, JL (2005). "Fever control in septic shock: beneficial or harmful?". Shock (Augusta, Ga.) 23 (6): 516–20.
- Schulman, CI, Namias, N, Doherty, J, Manning, RJ, Li, P, Elhaddad, A, Lasko, D, Amortegui, J, Dy, CJ, Dlugasch, Lucie, Baracco, Gio, Cohn, Stephen M. (2005). "The effect of antipyretic therapy upon outcomes in critically ill patients: a randomized, prospective study". Surgical infections 6 (4): 369–75.
- Rantala, S, Vuopio-Varkila, J, Vuento, R, Huhtala, H, Syrjänen, J (2009). "Predictors of mortality in beta-hemolytic streptococcal bacteremia: a population-based study". The Journal of infection 58 (4): 266–72.
- Fischler, M.P., Reinhart, W.H. (1997). "Fever: friend or enemy?". Schweiz Med Wochenschr 127 (20): 864–70.
- Craven, R and Hirnle, C. (2006). Fundamentals of nursing: Human health and function. Fourth edition. p. 1044
- Lewis, SM, Heitkemper, MM, and Dirksen, SR. (2007). Medical-surgical nursing: Assessment and management of clinical problems. sixth edition. p. 212
- "Fever". Medline Plus Medical Encyclopedia.
- "What To Do If You Get Sick: 2009 H1N1 and Seasonal Flu".
- Meremikwu M, Oyo-Ita A; Oyo-Ita (2003). Meremikwu, Martin M, ed. "Physical methods for treating fever in children". Cochrane Database Syst Rev (2): CD004264.
- "Fever". National Institute of Health.
- Guppy, MP; Mickan, SM, Del Mar, CB, Thorning, S, Rack, A; Del Mar, C. B.; Thorning, S; Rack, A (Feb 16, 2011). Guppy, Michelle PB, ed. "Advising patients to increase fluid intake for treating acute respiratory infections". Cochrane database of systematic reviews (Online) (2): CD004419.
- Perrott DA, Piira T, Goodenough B, Champion GD; Piira; Goodenough; Champion (June 2004). "Efficacy and safety of acetaminophen vs ibuprofen for treating children's pain or fever: a meta-analysis". Arch Pediatr Adolesc Med 158 (6): 521–6.
- Hay AD, Redmond NM, Costelloe C et al. (May 2009). "Paracetamol and ibuprofen for the treatment of fever in children: the PITCH randomised controlled trial". Health Technol Assess 13 (27): iii–iv, ix–x, 1–163.
- Southey ER, Soares-Weiser K, Kleijnen J; Soares-Weiser; Kleijnen (September 2009). "Systematic review and meta-analysis of the clinical safety and tolerability of ibuprofen compared with paracetamol in paediatric pain and fever". Curr Med Res Opin 25 (9): 2207–22.
- Meremikwu M, Oyo-Ita A; Oyo-Ita (2002). Meremikwu, Martin M, ed. "Paracetamol for treating fever in children". Cochrane Database Syst Rev (2): CD003676.
- Autret E, Reboul-Marty J, Henry-Launois B et al. (1997). "Evaluation of ibuprofen versus aspirin and paracetamol on efficacy and comfort in children with fever". Eur. J. Clin. Pharmacol. 51 (5): 367–71.
- "2.9 Antiplatelet drugs".
- Wong, T; Stang, AS; Ganshorn, H; Hartling, L; Maconochie, IK; Thomsen, AM; Johnson, DW (Oct 30, 2013). Wong, Tiffany, ed. "Combined and alternating paracetamol and ibuprofen therapy for febrile children". The Cochrane database of systematic reviews 10: CD009572.
- Nassisi, D; Oishi, ML (January 2012). "Evidence-based guidelines for evaluation and antimicrobial therapy for common emergency department infections". Emergency medicine practice 14 (1): 1–28; quiz 28–9.
- Sajadi, MM; Bonabi, R; Sajadi, MR; Mackowiak, PA (October 2012). "Akhawayni and the first fever curve.". Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 55 (7): 976–80.
- Crocetti M, Moghbeli N, Serwint J; Moghbeli; Serwint (June 2001). "Fever phobia revisited: have parental misconceptions about fever changed in 20 years?". Pediatrics 107 (6): 1241–6.
- Klass, Perri (10 January 2011). "Lifting a Veil of Fear to See a Few Benefits of Fever". The New York Times.
- "Equusite Vital Signs". www.equusite.com. Retrieved 2010-03-22.
- "Body Temperature of the Camel and Its Relation to Water Economy". ajplegacy.physiology.org. Retrieved 2010-03-22.
- Thomas, Matthew B.; Simon Blanford (July 2003). "Thermal biology in insect-parasite interactions". Trends in Ecology & Evolution 18 (7): 344–350.
- Rhoades, R. and Pflanzer, R. Human physiology, third edition, chapter 27 Regulation of body temperature, p. 820 Clinical focus: pathogenesis of fever. ISBN 0-03-005159-2
- Fever and Taking Your Child's Temperature
- US National Institute of Health factsheet
- Drugs most commonly associated with the adverse event Pyrexia (Fever) as reported the FDA